Description
GCAD is funded by the NIA to harmonize relevant whole genome/exome sequencing data to enable the identification of risk, causative, and protective genetic variants and to support downstream therapeutic target discovery. GCAD is responsible for implementing standardized and harmonized pipelines for processing and quality control (QC) variants, indels, and structural variants. For all these genetic variations, GCAD generates project-level sequence datasets and companion datasets, annotating them, and making them publicly available for research. The GCAD-QC working group meeting is used to discuss genomic data production, pipeline development, pipeline testing and updates, QC, and release progress.